• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于模拟建模估计的严格血糖控制的血糖仪性能标准。

Glucose meter performance criteria for tight glycemic control estimated by simulation modeling.

机构信息

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

Clin Chem. 2010 Jul;56(7):1091-7. doi: 10.1373/clinchem.2010.145367. Epub 2010 May 28.

DOI:10.1373/clinchem.2010.145367
PMID:20511447
Abstract

BACKGROUND

Glucose meter analytical performance criteria required for safe and effective management of patients on tight glycemic control (TGC) are not currently defined. We used simulation modeling to relate glucose meter performance characteristics to insulin dosing errors during TGC.

METHODS

We used 29,920 glucose values from patients on TGC at 1 institution to represent the expected distribution of glucose values during TGC, and we used 2 different simulation models to relate glucose meter analytical performance to insulin dosing error using these 29,920 initial glucose values and assuming 10%, 15%, or 20% total allowable error (TEa) criteria.

RESULTS

One-category insulin dosing errors were common under all error conditions. Two-category insulin dosing errors occurred more frequently when either 20% or 15% TEa was assumed compared with 10% total error. Dosing errors of 3 or more categories, those most likely to result in hypoglycemia and thus patient harm, occurred infrequently under all error conditions with the exception of 20% TEa.

CONCLUSIONS

Glucose meter technologies that operate within a 15% total allowable error tolerance are unlikely to produce large (>or=3-category) insulin dosing errors during TGC. Increasing performance to 10% TEa should reduce the frequency of 2-category insulin dosing errors, although additional studies are necessary to determine the clinical impact of such errors during TGC. Current criteria that allow 20% total allowable error in glucose meters may not be optimal for patient management during TGC.

摘要

背景

目前尚未定义用于安全有效地管理严格血糖控制(TGC)患者的血糖仪分析性能标准。我们使用模拟模型将血糖仪性能特征与 TGC 期间的胰岛素剂量错误相关联。

方法

我们使用来自 1 个机构的 TGC 患者的 29920 个血糖值来代表 TGC 期间血糖值的预期分布,我们使用 2 个不同的模拟模型,使用这 29920 个初始血糖值,并假设 10%、15%或 20%的总允许误差(TEa)标准,将血糖仪分析性能与胰岛素剂量错误相关联。

结果

在所有误差条件下,一类胰岛素剂量错误很常见。当假设 20%或 15%的 TEA 与 10%的总误差相比,二类胰岛素剂量错误发生的频率更高。最有可能导致低血糖和患者伤害的三类或更多类别的剂量错误在所有误差条件下都很少发生,除了 20%的 TEA。

结论

在 TGC 期间,血糖仪技术在 15%的总允许误差容差内运行不太可能产生大(>或=3 类)胰岛素剂量错误。将性能提高到 10%TEa 应该会降低 2 类胰岛素剂量错误的频率,尽管还需要进一步的研究来确定在 TGC 期间此类错误的临床影响。目前允许血糖仪总允许误差为 20%的标准可能不适合 TGC 期间的患者管理。

相似文献

1
Glucose meter performance criteria for tight glycemic control estimated by simulation modeling.基于模拟建模估计的严格血糖控制的血糖仪性能标准。
Clin Chem. 2010 Jul;56(7):1091-7. doi: 10.1373/clinchem.2010.145367. Epub 2010 May 28.
2
Empiric validation of simulation models for estimating glucose meter performance criteria for moderate levels of glycemic control.针对中等血糖控制水平的血糖仪性能指标进行模拟模型的经验验证。
Diabetes Technol Ther. 2013 Dec;15(12):996-1003. doi: 10.1089/dia.2013.0086. Epub 2013 Sep 13.
3
Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose.血糖仪的质量规范:通过胰岛素剂量误差的模拟模型进行评估
Clin Chem. 2001 Feb;47(2):209-14.
4
Bedside Glucose Monitoring-Is it Safe? A New, Regulatory-Compliant Risk Assessment Evaluation Protocol in Critically Ill Patient Care Settings.床边血糖监测——安全吗?一种适用于重症患者护理环境的、符合监管要求的新风险评估评估方案。
Crit Care Med. 2017 Apr;45(4):567-574. doi: 10.1097/CCM.0000000000002252.
5
Estimated Risk for Insulin Dose Error Among Hospital Patients Due to Glucose Meter Hematocrit Bias in 2020.2020 年由于血糖仪红细胞压积偏差导致医院患者胰岛素剂量错误的估计风险。
Arch Pathol Lab Med. 2020 Oct 1;144(10):1204-1208. doi: 10.5858/arpa.2020-0101-RA.
6
Impact of Glucose Meter Error on Glycemic Variability and Time in Target Range During Glycemic Control After Cardiovascular Surgery.血糖仪误差对心血管手术后血糖控制期间血糖变异性及达标时间的影响
J Diabetes Sci Technol. 2015 Aug 25;10(2):336-42. doi: 10.1177/1932296815602099.
7
A physiological Intensive Control Insulin-Nutrition-Glucose (ICING) model validated in critically ill patients.一项在危重症患者中验证的生理强化控制胰岛素-营养-血糖(ICING)模型。
Comput Methods Programs Biomed. 2011 May;102(2):192-205. doi: 10.1016/j.cmpb.2010.12.008. Epub 2011 Feb 1.
8
Impact of variation in patient response on model-based control of glycaemia in critically ill patients.患者反应变化对危重症患者血糖模型控制的影响。
Comput Methods Programs Biomed. 2013 Feb;109(2):211-9. doi: 10.1016/j.cmpb.2011.08.007. Epub 2011 Sep 22.
9
An insulin infusion protocol in critically ill cardiothoracic surgery patients.重症心胸外科手术患者的胰岛素输注方案
Ann Pharmacother. 2004 Jul-Aug;38(7-8):1123-9. doi: 10.1345/aph.1E018. Epub 2004 May 18.
10
Glucose control in the intensive care unit.重症监护病房中的血糖控制
Crit Care Med. 2009 May;37(5):1769-76. doi: 10.1097/CCM.0b013e3181a19ceb.

引用本文的文献

1
Extended Review Concerning the Integration of Electrochemical Biosensors into Modern IoT and Wearable Devices.关于电化学生物传感器在现代物联网和可穿戴设备中集成的扩展综述。
Biosensors (Basel). 2024 Apr 25;14(5):214. doi: 10.3390/bios14050214.
2
Device integration of electrochemical biosensors.电化学生物传感器的设备集成
Nat Rev Bioeng. 2023;1(5):346-360. doi: 10.1038/s44222-023-00032-w. Epub 2023 Feb 24.
3
Flight and diabetes.飞行与糖尿病。
Anatol J Cardiol. 2021 Aug;25(Suppl 1):20-23. doi: 10.5152/AnatolJCardiol.2021.S108.
4
Do We Need the Replacement of YSI 2300? A View from the Clinical Laboratory.我们需要更换 YSI 2300 吗?临床实验室的观点。
J Diabetes Sci Technol. 2022 May;16(3):756-759. doi: 10.1177/19322968211007170. Epub 2021 May 17.
5
Biological variation: Understanding why it is so important?生物变异:理解其为何如此重要?
Pract Lab Med. 2021 Jan 4;23:e00199. doi: 10.1016/j.plabm.2020.e00199. eCollection 2021 Jan.
6
Comparison of Accuracy Guidelines for Hospital Glucose Meters.血糖仪准确度比对指南比较。
J Diabetes Sci Technol. 2020 May;14(3):546-552. doi: 10.1177/1932296819898277. Epub 2020 Jan 25.
7
Evaluation of Precision and Bias Specifications Required to Achieve the 2018 FDA Guidance Criteria for Glucose Meter Performance Using Simulation Models.使用仿真模型评估达到 2018 年 FDA 血糖仪性能指导标准所需的精度和偏差规范。
J Diabetes Sci Technol. 2020 May;14(3):513-518. doi: 10.1177/1932296819889639. Epub 2019 Nov 21.
8
A Simulation Study to Assess the Effect of Analytic Error on Neonatal Glucose Measurements Using the Canadian Pediatric Society Position Statement Action Thresholds.一项使用加拿大儿科学会立场声明行动阈值评估分析误差对新生儿血糖测量影响的模拟研究。
J Diabetes Sci Technol. 2020 May;14(3):519-525. doi: 10.1177/1932296819884923. Epub 2019 Nov 6.
9
Toward a Framework for Outcome-Based Analytical Performance Specifications: A Methodology Review of Indirect Methods for Evaluating the Impact of Measurement Uncertainty on Clinical Outcomes.迈向基于结果的分析性能规格框架:评估测量不确定度对临床结果影响的间接方法的方法学综述。
Clin Chem. 2019 Nov;65(11):1363-1374. doi: 10.1373/clinchem.2018.300954. Epub 2019 Aug 23.
10
Modeling of Diabetes and Its Clinical Impact.糖尿病建模及其临床影响
J Diabetes Sci Technol. 2018 Sep;12(5):976-984. doi: 10.1177/1932296818785642. Epub 2018 Jul 13.